APA (7th ed.) Citation

Chiu, C., Chen, Y., & Chen, Y. (2026). Benefit of Latanoprostene Bunod (Vyzulta) for Glaucoma Switched from Prior Pharmacotherapy: A Retrospective Cohort Study in Taiwan. Ophthalmology & Therapy, 15(6), 1941. https://doi.org/10.1007/s40123-026-01367-4

Chicago Style (17th ed.) Citation

Chiu, Chen-Jui, Ying-Ying Chen, and Yi-Shan Chen. "Benefit of Latanoprostene Bunod (Vyzulta) for Glaucoma Switched from Prior Pharmacotherapy: A Retrospective Cohort Study in Taiwan." Ophthalmology & Therapy 15, no. 6 (2026): 1941. https://doi.org/10.1007/s40123-026-01367-4.

MLA (9th ed.) Citation

Chiu, Chen-Jui, et al. "Benefit of Latanoprostene Bunod (Vyzulta) for Glaucoma Switched from Prior Pharmacotherapy: A Retrospective Cohort Study in Taiwan." Ophthalmology & Therapy, vol. 15, no. 6, 2026, p. 1941, https://doi.org/10.1007/s40123-026-01367-4.